Megan Redshaw
J.D.
Megan Redshaw is an attorney and investigative journalist with a background in political science. She is also a traditional naturopath with additional certifications in nutrition and exercise science.
LATEST
More Than a Quarter of ‘Healthy’ Older Adults Have Asymptomatic Heart Valve Disease: New Study
Most cases were mild and primarily affected older adults over 75 years old.
Kids Given Technology to Pacify Tantrums Don’t Learn to Regulate Emotions: New Study
Children come to rely on digital devices for emotional regulation instead of developing internal self-regulatory skills.
Popular Weight-Loss Drug May Treat Obstructive Sleep Apnea: New Study
Tirzepatide, an antidiabetic and weight-loss medication marketed as Mounjaro and Zepbound, may reduce obesity, an underlying factor in sleep apnea.
LSD Use May Increase Psychological Distress in Stressful Situations: New Study
Recreational use of lysergic acid diethylamide was linked to 1.6 to 1.7 times higher risk of severe psychological distress following job loss.
Early Treatment With Fluvoxamine May Reduce Severe COVID-19 Outcomes: Review
Early treatment with higher doses of the SSRI fluvoxamine may reduce COVID-19 clinical deterioration, mortality, and long-COVID complications.
NIH Documents Show $1.6 Billion Long COVID Initiative So Far Falls Short of Goals
Congress more than three years ago allocated $1.6 billion to the NIH to define, understand, and treat long COVID—and there’s largely nothing to show for it.
FDA Advisors Unanimously Recommend New Drug for Alzheimer’s Disease
The risk-benefit ratio was deemed ‘acceptable’ even though more adverse events, including deaths, occurred in the drug treatment group.
Infants Exposed to SARS-CoV-2 During Pregnancy 10 Times More Likely to Have Developmental Delays: Study
A recent study found infants exposed to COVID-19 in utero scored lower in communication, gross motor, fine motor, problem-solving, and personal-social domains.
FDA Advisory Panel Votes Against Using MDMA Drug ‘Ecstasy’ as Treatment for PTSD
FDA advisors cited concerns over clinical data, selection and expectation bias, and the safety risks of MDMA.
Exercise May Be More Effective Than Antidepressants in Treating Depression
A review in the BMJ found the largest reductions in depression with dance and intense exercise.
